ATE36852T1 - Substituierte 6-(thien-2-yl)-3(2h)-pyridazinone und verfahren zur herstellung. - Google Patents

Substituierte 6-(thien-2-yl)-3(2h)-pyridazinone und verfahren zur herstellung.

Info

Publication number
ATE36852T1
ATE36852T1 AT84106391T AT84106391T ATE36852T1 AT E36852 T1 ATE36852 T1 AT E36852T1 AT 84106391 T AT84106391 T AT 84106391T AT 84106391 T AT84106391 T AT 84106391T AT E36852 T1 ATE36852 T1 AT E36852T1
Authority
AT
Austria
Prior art keywords
pyridazinones
thien
substituted
preparation
formula
Prior art date
Application number
AT84106391T
Other languages
English (en)
Inventor
Gerd Dr Hilboll
Sigurd Dr Leyck
Gerrit Dr Prop
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Application granted granted Critical
Publication of ATE36852T1 publication Critical patent/ATE36852T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT84106391T 1983-06-10 1984-06-05 Substituierte 6-(thien-2-yl)-3(2h)-pyridazinone und verfahren zur herstellung. ATE36852T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833321012 DE3321012A1 (de) 1983-06-10 1983-06-10 Substituierte 4,5-dihydro-6-(thien-2-yl)-3(2h)-pyridazinone und 6-(thien-2-yl)-3(2h)-pyridazinone sowie verfahren zu ihrer herstellung
EP84106391A EP0128502B1 (de) 1983-06-10 1984-06-05 Substituierte 6-(Thien-2-yl)-3(2H)-pyridazinone und Verfahren zur Herstellung

Publications (1)

Publication Number Publication Date
ATE36852T1 true ATE36852T1 (de) 1988-09-15

Family

ID=6201162

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84106391T ATE36852T1 (de) 1983-06-10 1984-06-05 Substituierte 6-(thien-2-yl)-3(2h)-pyridazinone und verfahren zur herstellung.

Country Status (10)

Country Link
US (1) US4667033A (de)
EP (1) EP0128502B1 (de)
JP (1) JPS6041674A (de)
AT (1) ATE36852T1 (de)
DE (2) DE3321012A1 (de)
DK (1) DK284284A (de)
ES (1) ES533243A0 (de)
GR (1) GR82025B (de)
PT (1) PT78715B (de)
ZA (1) ZA844286B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783463A (en) * 1985-10-23 1988-11-08 Rorer Pharmaceutical Corporation Pyridyl-pyridazinone and pyridyl-pyrazolinone compounds and their use in the treatment of congestive heart failure
DE3606105A1 (de) * 1986-02-26 1987-08-27 Nattermann A & Cie Verfahren zur herstellung von imidazolyl-thiophenaldehyden
DE3626865A1 (de) * 1986-08-08 1988-02-11 Boehringer Mannheim Gmbh Neue pyridazinon-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
TW414795B (en) * 1996-07-01 2000-12-11 Yamanouchi Pharma Co Ltd A thiophene derivative and the pharmaceutical composition
DE102005057924A1 (de) * 2005-12-05 2007-06-06 Merck Patent Gmbh Pyridazinonderivate
WO2013097052A1 (en) 2011-12-30 2013-07-04 Abbott Laboratories Bromodomain inhibitors
US20150174034A1 (en) 2013-03-13 2015-06-25 Avon Products, Inc. Tyrosinase inhibitors
US9364405B2 (en) 2013-03-13 2016-06-14 Avon Products, Inc. Tyrosinase inhibitors
WO2014158943A1 (en) * 2013-03-13 2014-10-02 Avon Products, Inc Tyrosinase inhibitors
TWI764237B (zh) 2016-04-15 2022-05-11 美商艾伯維有限公司 溴域抑制劑

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1105281A (en) * 1965-03-03 1968-03-06 Seperic Improvements in and relating to new pyridazone derivatives and process for preparing same
CH557819A (de) * 1970-11-12 1975-01-15 Sandoz Ag Verfahren zur herstellung von neuen 2-(2-hydroxyalkyl)4,5-dihydro-pyridazin(2h)-3-onen.
DE2845456A1 (de) * 1978-10-19 1980-08-14 Merck Patent Gmbh 6-arylpyridazin-3-one und verfahren zu ihrer herstellung
DE3130251A1 (de) * 1981-07-31 1983-02-17 A. Nattermann & Cie GmbH, 5000 Köln 6-(4-((omega)-(1-imidazolyl)-alkyl)-phenyl)-3-oxo -2,3,4,5-tetrahydro-pyridazine und deren saeureadditionssalze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3130252A1 (de) * 1981-07-31 1983-02-17 A. Nattermann & Cie GmbH, 5000 Köln 6-(5-((omega)-(1-imidazolyl)-alkyl)-thien-2-yl)-3-oxo-2,3,4,5-tetrahydro-pyridazine und deren saeureadditionssalze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
HU190412B (en) * 1981-09-17 1986-09-29 Warner-Lambert Co,Us Process for producing substituted 4,5-dihiydro-6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones and 6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones
IE54598B1 (en) * 1981-11-12 1989-12-06 Ici Plc Pharmaceutically-active pyridylvinylpyridazinones
US4521416A (en) * 1983-03-22 1985-06-04 Warner-Lambert Company 4,5-Dihydro-6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyridazinones and 6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyridazinones

Also Published As

Publication number Publication date
DK284284D0 (da) 1984-06-08
DK284284A (da) 1984-12-11
EP0128502B1 (de) 1988-08-31
ZA844286B (en) 1985-01-30
DE3473758D1 (en) 1988-10-06
ES8506306A1 (es) 1985-07-01
ES533243A0 (es) 1985-07-01
JPS6041674A (ja) 1985-03-05
PT78715A (pt) 1985-01-01
DE3321012A1 (de) 1984-12-13
EP0128502A1 (de) 1984-12-19
PT78715B (en) 1986-07-15
US4667033A (en) 1987-05-19
GR82025B (de) 1984-12-12

Similar Documents

Publication Publication Date Title
ATE168101T1 (de) Arylpyridazinone
FI971967A (fi) Dioksomorfoliinien käyttö sisäloisten torjuntaan, uusia dioksomorfiineja ja menetelmä niiden valmistamiseksi
DK417185D0 (da) 4,5-dihydro-3(2h)-pyridazinoner, fremgangsmaade til fremstilling derafog deres anvendelse
FI932229A (fi) Azabicykliska bryggderivat
DK422583A (da) Fremgangsmaade til fremstilling af diazobicyclo-(3,3,1)-nonaner
DE69107387D1 (de) Verfahren zur Herstellung von halberstarrten Metallzusammensetzungen.
ATE36852T1 (de) Substituierte 6-(thien-2-yl)-3(2h)-pyridazinone und verfahren zur herstellung.
ATE34741T1 (de) 6-(acylaminoaryl)-3(2h)-pyridazinonderivate, ihre herstellung und verwendung.
ATE92498T1 (de) Primycinkomponenten und verfahren zur trennung des antibiotischen komplexes.
DK247888A (da) Aminosyrederivater af 4-benzyl-1-(2h)-phthalazinon
FI843354A (fi) Foerfarande foer framstaellning av nya 4-fenyl-4-oxo-2-ensmoersyraderivat.
DE3786491T2 (de) Gerät zur Ableitung des Minutenvolumens der rechten Herzkammer aus Temperaturverdünnungskurven hoher Wiedergabequalität.
ES8601916A1 (es) Un procedimiento para la preparacion de nuevos derivados de 4,5-dihidro-2h-piridazin-3-ona.
ATE449063T1 (de) Verfahren zur herstellung von beta- hydroxyalkylamiden
ATA408982A (de) Verfahren zur herstellung von 6-(nied.alkoxy)-5(triflourmethyl)-1-naphathalincarbons|ure
ATE27453T1 (de) 6-aryl-4,5-dihydro-3(2h)-pyridazinone,ihre herstellung und verwendung.
JPS539321A (en) Agri-horticultural fungicide
DE3880967D1 (de) Verwendung von alkylphosphaten zur stabilisierung thixotropischer zusammensetzungen.
ATE12388T1 (de) Verfahren zur herstellung von 3-chloro-6-(2hydroxy-phenyl)pyridazinen.
DE69101555T2 (de) Verfahren zur herstellung von sulfinyl-pristinamycin iib.
ATA516779A (de) Verfahren zur herstellung von 4,5-dichlor-2phenyl-3(2h)-pyridazinon aus 4-amino-5-chlor-2- phenyl-3(2h)-pyridazinon
DE69409101D1 (de) Verfahren zur herstellung von 6-fluoro-2-halogeno-chinolin
ATA299480A (de) Verfahren zur herstellung von 6-phenyl-3(2h) pyridazinon
ATE25248T1 (de) Verfahren zur herstellung von phenylpyridazinverbindungen.
ATA104983A (de) Verfahren zur herstellung neuer substituierter aethenylderivate des 1h-pyrazolo-(1,5-a)-pyrimidins

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee